RŌNIN V6 · ON THE LABEL AT ROW 13 OF 40
Bacillus coagulans GBI-30.
GBI-30 6086, ≥5b cfu end-of-life. In Rōnin at 5 billion CFU per serving - published to the milligram, tested every batch.
5 billion CFUPER SERVING · 30 SERVINGS PER POUCH
AS PRINTED ON THE LABEL
- FORM
- GBI-30 6086
- DOSE PER SERVING
- 5 billion CFU
- STANDARDISATION
- ≥5B CFU end-of-life
- GROUP
- Gut (Synbiotic)
WHY IT’S IN
On the label for a reason.
Bacillus coagulans GBI-30 sits in the Gut (Synbiotic) group at 5 billion CFU - GBI-30 6086; ≥5B CFU end-of-life. The 4 papers below are the reasoning: we cite them, and we claim nothing beyond them.
THE RESEARCH · 4 PEER-REVIEWED PAPERS
Peer-reviewed. Or it is not on the page.
Human research supporting this ingredient at this dose. Every entry names its journal, carries its PubMed ID, and links to the source.
- 01PMID 19332970
Bacillus coagulans significantly improved abdominal pain and bloating in patients with IBS.
Hun L. (2009). Postgrad Med. 121(2):119–24.
READ ON PUBMED → - 02PMID 19332969
A patented strain of Bacillus coagulans increased immune response to viral challenge.
Baron M. (2009). Postgrad Med. 121(2):114–8.
READ ON PUBMED → - 03PMID 27547577
Probiotic Bacillus coagulans GBI-30, 6086 reduces exercise-induced muscle damage and increases recovery.
Jäger R, et al. (2016). PeerJ. 4:e2276.
READ ON PUBMED → - 04PMID 20140275
Effects of a proprietary Bacillus coagulans preparation on symptoms of diarrhea-predominant irritable bowel syndrome.
Dolin BJ. (2009). Methods Find Exp Clin Pharmacol. 31(10):655–9.
READ ON PUBMED →
REFERENCES VERIFIED AGAINST NCBI · TITLES AS PUBLISHED
Browse the full research library →WORKS ALONGSIDE · SAME LABEL GROUP
THE HONEST LIMITS
We publish the dose and the studies, and we claim nothing beyond them. If the evidence changes, this page changes.